abberior instruments
2024
Molecular Psychiatry
The schizophrenia risk gene C4 induces pathological synaptic loss by impairing AMPAR trafficking
Authors:
Rhushikesh A. Phadke, Alison Brack, Luke A. Fournier, Ezra Kruzich, Mingqi Sha, Ines Picard, Connor Johnson, Dimitri Stroumbakis, Maria Salgado, Charlotte Yeung, Berta Escude Velasco, Yen Yu Liu, Alberto Cruz-Martín
Keywords:
Cell biology; Molecular biology; Neuroscience; Schizophrenia; AMPAR; complement receptor 3; CR3; SNX27; synaptic plasticity; endo-lysosomal trafficking
Abstract:
Neuroimmune interactions play a significant role in regulating synaptic plasticity in both the healthy and diseased brain. The complement pathway, an extracellular proteolytic cascade, exemplifies these interactions. Its activation triggers microglia-dependent synaptic elimination via the complement receptor 3 (CR3). Current models of pathological complement activity in the brain propose that accelerated synaptic loss resulting from overexpression of C4 (C4-OE), a gene associated with schizophrenia, follows this pathway. Here, we report that C4-mediated cortical hypoconnectivity is CR3-independent. Instead, C4-OE triggers impaired GluR1 trafficking through an intracellular mechanism involving the endosomal protein SNX27, resulting in pathological synaptic loss. Moreover, C4 circuit alterations in the prefrontal cortex, a brain region associated with neuropsychiatric disorders, were rescued by increasing neuronal levels of SNX27, which we identify as an interacting partner of this neuroimmune protein. Our results link excessive complement activity to an intracellular endo-lysosomal trafficking pathway altering synaptic plasticity.